Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation

Journal of Clinical Microbiology

Volumn 50, Issue 12, 2012, Pages 3968-3976

  Keating, Sheila M ^a,b   Hanson, Debra ^c   Lebedeva, Mila ^a   Laeyendecker, Oliver ^d,e   Ali Napo, N'ko L ^f,g   Owen, S Michele ^c   Stramer, Susan L ^h   Moore, Richard D ^e   Norris, Philip J ^a,b   Busch, Michael P ^a,b  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f WADSWORTH CENTER   (United States)

^g STATE UNIVERSITY OF NEW YORK   (United States)

^h AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS PATIENT; ANALYTICAL PARAMETERS; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AVIDITY INDEX; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE DURATION; ENZYME IMMUNOASSAY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MORBIDITY; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY ANALYSIS; SEROCONVERSION;

ANTIBODY AFFINITY; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; SENSITIVITY AND SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 84869224218     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01454-12     Document Type: Article

References (26)

1. Beyrer C, Nelson KE. 1997. Loss to follow-up effect in investigations of HIV-1 incidence. Lancet 349:649-650. (Pubitemid 27101905)
2. Brookmeyer R. 2010. Measuring the HIV/AIDS epidemic: approaches and challenges. Epidemiol. Rev. 32:26-37.
3. Brookmeyer R, Quinn TC. 1995. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am. J. Epidemiol. 141:166-172.
4. Busch MP, et al. 2010. Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS (London, Engl.) 24:2763-2771.
5. Celum CL, et al. 2001. Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. J. Infect. Dis. 183:23-35. (Pubitemid 32043038)
6. Chawla A, et al. 2007. Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. J. Clin. Microbiol. 45:415-420.
7. Chetty C, et al. 2005. Vironostika HIV-1 Plus O Microelisa System for the detection of antibodies to HIV-1, including Group O, in serum, plasma, or dried blood spots. HIV Diagnostics: New Developments and Challenges, 28 February to 1 March 2005, Orlando, FL. http://www.hivtestingconferencearchive.org/ hivtesting2005/CA1.htm.
8. Cimerman S, Sucupira MC, Lewi DS, Diaz RS. 2007. Less sensitive HIV-1 enzyme immunoassay as an adjuvant method for monitoring patients receiving antiretroviral therapy. AIDS Patient Care STDS 21:100-105. (Pubitemid 46394023)
9. Diaz RS, Kallas EG, Castelo A, Rawal BD, Busch MP. 1999. Use of a new 'less-sensitive enzyme immunoassay' testing strategy to identify recently infected persons in a Brazilian prison: estimation of incidence and epidemiological tracing. AIDS (London, Engl.) 13:1417-1418.
10. Duong YT, et al. 2012. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One 7:e33328. doi:10.1371/journal.pone.0033328.
11. Garcia MN, dos Ramos Farias MS, Avila MM, Rabinovich RD. 2011. Presence of p24-antigen associated to erythrocyte in HIV-positive individuals even in patients with undetectable plasma viral load. PLoS One 6:e14544. doi:10.1371/journal.pone.0014544.
12. Groopman JE, et al. 1985. Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders. Blood 66:742-744. (Pubitemid 15230791)
13. Guy R, et al. 2009. Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. Lancet Infect. Dis. 9:747-759.
14. Hallett TB, Ghys P, Barnighausen T, Yan P, Garnett GP. 2009. Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age. PLoS One 4:e5720. doi:10.1371/journal.pone.0005720.
15. Hallett TB, et al. 2008. Estimating incidence from prevalence in generalised HIV epidemics: methods and validation. PLoS Med. 5:e80. doi: 10.1371/journal.pmed.0050080.
16. Hargrove JW, et al. 2008. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS (London, Engl.) 22:511-518.
17. Highleyman L. 1999. Detuned assay used to track recent infections. Beta 12:6, 78.
18. Janssen RS, et al. 1998. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 280:42-48. (Pubitemid 28414995)
19. Kimura T, et al. 2002. Reconstitution of spontaneous neutralizing antibody response against autologous human immunodeficiency virus during highly active antiretroviral therapy. J. Infect. Dis. 185:53-60. (Pubitemid 34043016)
20. Martro E, et al. 2005. Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections. J. Clin. Microbiol. 43:6197-6199. (Pubitemid 43100691)
21. Moore RD. 1998. Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17(Suppl 1):S38-S41. (Pubitemid 128708058)
22. Murphy G, Parry JV. 2008. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill. 13:pii=18966. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18966.
23. Parekh BS, et al. 2011. Determination of mean recency period for estimation of HIV type 1 incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res. Hum. Retroviruses 27:265-273.
24. Parekh BS, et al. 2002. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res. Hum. Retroviruses 18:295-307. (Pubitemid 34253148)
25. Rawal BD, et al. 2003. Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J. Acquir. Immune Defic. Syndr. 33:349-355. (Pubitemid 36859061)
26. Samuelsson A, Brostrom C, van Dijk N, Sonnerborg A, Chiodi F. 1997. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection- correlation with clinical progression, viral load, and loss of humoral immunity. Virology 238:180-188. (Pubitemid 28218136)